Discover how monoclonal antibodies work, the conditions they can help treat and how they are produced at scale. Explore recent clinical advances and Boccard’s capabilities in process equipment, utilities integration and GMP project delivery.

Neurological biologics require scalable cell culture, purification, clean utilities and GMP-ready facilities for reliable commercial production at global scale.

As demand for immunoglobulin therapies grows across rare autoimmune diseases, manufacturers must expand plasma fractionation capacity while maintaining strict GMP and viral safety standards. This case study shows how Boccard delivered a large-scale, integrated immunoglobulin production facility designed to support long-term IVIg supply.

Modern process solutions enable the safe, efficient, and GMP-compliant production of oncology drugs. Thanks to advanced pharmaceutical technologies, it is possible to scale up production while maintaining the highest quality and full process control.

As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.